Cure Pharmaceutical Holding Corp. (CURR)
NASDAQ · Technology
Cure Pharmaceutical Holding Corp. annual/quarterly shareholder equity history from 2023 to 2024. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Cure Pharmaceutical Holding Corp. shareholder equity for the quarter ending December 31, 2024 were -66.0M, a 5.15% increase year-over-year.
- Cure Pharmaceutical Holding Corp. shareholder equity for 2024 were -66.0M, a 5.15% increase from 2023.
- Cure Pharmaceutical Holding Corp. shareholder equity for 2023 were -62.8M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cure Pharmaceutical Holding Corp. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2024 | $-66 |
| 2023 | $-63 |
| Cure Pharmaceutical Holding Corp. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2024-12-31 | $-66 |
| 2023-12-31 | $-63 |
Cure Pharmaceutical Holding Corp. Shareholder Equity — FAQ
Cure Pharmaceutical Holding Corp. (CURR) shareholder equity over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CURR's shareholder equity history?
The chart and table above show Cure Pharmaceutical Holding Corp.'s shareholder equity by year and by quarter, including the growth rate.